Status:
ACTIVE_NOT_RECRUITING
Natural History of Neuronal Ceroid Lipofuscinosis, Batten's CLN6 Diseae
Lead Sponsor:
Emily de los Reyes
Conditions:
Batten Disease
CLN6
Eligibility:
All Genders
2-25 years
Brief Summary
CLN6 is a rare, neurodegenerative disease that causes progressive loss of acquired skills with motor delay, visual loss, seizures and ataxia. The investigators propose a natural history study of this ...
Detailed Description
Neuronal Ceroid Lipofuscinosis (NCL) is the most common childhood neurodegenerative disorder characterized by accumulation of autofluorescent waxy lipopigments in the brain and other tissues. The symp...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of genotypic diagnosis of CLN6
Exclusion
- Patients who do not have a genotypic diagnosis of CLN6
Key Trial Info
Start Date :
January 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT03285425
Start Date
January 1 2017
End Date
December 1 2026
Last Update
July 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nationwide Children's Hospital
Columbus, Ohio, United States, 43205